Drugs Currently Approved for Treatment of HIV as of August,
2004 |
|||
Brand Name |
Generic Name |
Abbreviation |
Pharmaceutical Company |
Protease Inhibitors (PIs) |
|||
| Agenerase | amprenavir | APV | GlaxoSmithKline |
| Crixivan | indinavir | IDV | Merck & Co. |
| Fortovase | saquinavir (Soft Gel Cap) | SQV (SGC) | Hoffmann-La Roche |
| Invirase | saquinavir (Hard Gel Cap) | SQV (HGC) | Hoffmann-La Roche |
| Kaletra | lopinavir + ritonavir | LPV/r | Abbott Laboratories |
| Lexiva | fosamprenavir | FPV | GlaxoSmithKline |
| Norvir | ritonavir | RTV | Abbott Laboratories |
| Reyataz | atazanavir | ATZ | Bristol-Myers Squibb |
| Viracept | nelfinavir | NFV | Pfizer |
Nucleoside/Nucleotide
Reverse Transcriptase Inhibitors (NRTIs)
|
|||
| Combivir | zidovudine + lamivudine | AZT + 3TC (CBV) | GlaxoSmithKline |
| Emtriva | emtricitabine | FTC | Gilead Sciences |
| Epivir | lamivudine | 3TC | GlaxoSmithKline |
| Epzicom | abacavir + lamivudine | ABC + 3TC | GlaxoSmithKline |
| Hivid | zalcitabine | ddC | Hoffmann-La Roche |
| Retrovir | zidovudine | AZT or ZDV | GlaxoSmithKline |
| Trizivir | abacavir + zidovudine + lamivudine | ABC + AZT + 3TC (TZV) | GlaxoSmithKline |
| Truvada | tenofovir DF + emtricitabine | TDF + FTC | Gilead Sciences |
| Videx | didanosine: buffered versions | ddI | Bristol-Myers Squibb |
| Videx EC | didanosine: delayed-release capsules | ddI | Bristol-Myers Squibb |
| Viread | tenofovir disoproxil fumarate | TDF | Gilead Sciences |
| Zerit | stavudine | d4T | Bristol-Myers Squibb |
| Ziagen | abacavir | ABC | GlaxoSmithKline |
Non-Nucleoside Reverse Transcriptase Inhibitors
(NNRTIs) |
|||
| Rescriptor | delavirdine | DLV | Pfizer |
| Sustiva | efavirenz | EFV | Bristol-Myers Squibb |
| Viramune | nevirapine | NVP | Boehringer Ingelheim |
Fusion Inhibitor |
|||
| Fuzeon | enfuvirtide | ENF (T-20) | Roche Laboratories |